Please send all feedback to: doc@psychiatrix.com
Los Angeles area residents call 818-991-8376 for appt.
A novel medication, PROVIGIL (modafinil), has been shown effective in the treatment of daytime sleepiness.
This medication has FDA approval for use in treating narcolepsy.* Its use in treating daytime sleepiness is "off label."
Provigil may also have value in treating some forms of dementia and ADHD.
Some of the features of PROVIGIL include:
1 - It is not related to the traditional stimulants such as methylphenidate (Ritalin) and the amphetamines.
2 - It does not seem to cause irritability and motor restlessness often associated with amphetamines.
3 - It seems to have more specific effects on the brain sleep mechanism vs. amphetamines.
4 - It is not a CONTROLLED SUBSTANCE - a triplicate prescription is not required.
5 - It probably has less potential for abuse and misuse than other stimulants.
As with all medications there are potential side effects and other medical considerations to be evaluated prior to and during medication treatment. It is essential to consult with a psychiatrist, or other physician, knowledgeable about daytime sleepiness and related medical and psychiatric conditions.
PROVOGIL is frequently prescribed in the dosage range of 200mg to 400mg with a usual maximum of 600mg.
Dosing will vary depending on the physician's assessment of the patient's needs.
PROVIGIL is marketed in the US by Cephalon.
__________________
*Narcolepsy is a specific disorder characterized by paroxysmal sleep episodes and cataplexy, or sudden loss of muscle tone.
Please send all feedback to: doc@psychiatrix.com
Los Angeles area residents call 818-991-8376 for appt.